| Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21 ME Hatley, DM Patrick, MR Garcia, JA Richardson, R Bassel-Duby, ... Cancer cell 18 (3), 282-293, 2010 | 766 | 2010 |
| Targeting oxidative stress in embryonal rhabdomyosarcoma X Chen, E Stewart, AA Shelat, C Qu, A Bahrami, M Hatley, G Wu, ... Cancer cell 24 (6), 710-724, 2013 | 337 | 2013 |
| Allosteric determinants in guanine nucleotide-binding proteins ME Hatley, SW Lockless, SK Gibson, AG Gilman, R Ranganathan¶ Proceedings of the National Academy of Sciences 100 (24), 14445-14450, 2003 | 167 | 2003 |
| A mouse model of rhabdomyosarcoma originating from the adipocyte lineage ME Hatley, W Tang, MR Garcia, D Finkelstein, DP Millay, N Liu, J Graff, ... Cancer cell 22 (4), 536-546, 2012 | 148 | 2012 |
| Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems VP Kashi, ME Hatley, RL Galindo Nature Reviews Cancer 15 (7), 426-439, 2015 | 140 | 2015 |
| Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis K White, Y Dempsie, P Caruso, E Wallace, RA McDonald, H Stevens, ... Hypertension 64 (1), 185-194, 2014 | 111 | 2014 |
| Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors CJ Drummond, JA Hanna, MR Garcia, DJ Devine, AJ Heyrana, ... Cancer Cell 33 (1), 108-124. e5, 2018 | 83 | 2018 |
| MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease R Lakhia, S Hajarnis, D Williams, K Aboudehen, M Yheskel, C Xing, ... Journal of the American Society of Nephrology 27 (8), 2319-2330, 2016 | 81 | 2016 |
| Insights into pediatric rhabdomyosarcoma research: Challenges and goals ME Yohe, CM Heske, E Stewart, PC Adamson, N Ahmed, CR Antonescu, ... Pediatric blood & cancer 66 (10), e27869, 2019 | 78 | 2019 |
| PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma JA Hanna, MR Garcia, A Lardennois, PJ Leavey, D Maglic, A Fagnan, ... Oncogene 37 (15), 1991-2007, 2018 | 54 | 2018 |
| PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma JA Hanna, MR Garcia, JC Go, D Finkelstein, K Kodali, V Pagala, X Wang, ... Cell Death & Disease 7 (6), e2256-e2256, 2016 | 38 | 2016 |
| St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project Targeting oxidative stress in embryonal rhabdomyosarcoma X Chen, E Stewart, AA Shelat, C Qu, A Bahrami, M Hatley, G Wu, ... Cancer Cell 24 (6), 710-724, 2013 | 36 | 2013 |
| Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma S Singh, A Abu-Zaid, H Jin, J Fang, Q Wu, T Wang, H Feng, W Quarni, ... Science translational medicine 14 (653), eabq2096, 2022 | 22 | 2022 |
| Isolation and characterization of constitutively active mutants of mammalian adenylyl cyclase ME Hatley, BK Benton, J Xu, JP Manfredi, AG Gilman, RK Sunahara Journal of Biological Chemistry 275 (49), 38626-38632, 2000 | 22 | 2000 |
| Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity CG Langdon, KE Gadek, MR Garcia, MK Evans, KB Reed, M Bush, ... Nature communications 12 (1), 5520, 2021 | 18 | 2021 |
| Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma JA Hanna, CJ Drummond, MR Garcia, JC Go, D Finkelstein, JE Rehg, ... Cancer research 77 (22), 6109-6118, 2017 | 18 | 2017 |
| A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells CJ Drummond, ME Hatley Molecular & Cellular Oncology 5 (4), e1448246, 2018 | 16 | 2018 |
| Gas-phase methylation of the 2-hydroxypyridine/2-pyridone system by the dimethylchlorinium ion RAJ O'Hair, MA Freitas, JAR Schmidt, ME Hatley, TD Williams European Mass Spectrometry 1 (5), 457-463, 1995 | 13 | 1995 |
| PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors MB Searcy, RK Larsen IV, BT Stevens, Y Zhang, H Jin, CJ Drummond, ... Nature Communications 14 (1), 7291, 2023 | 11 | 2023 |
| Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia JL Kamens, S Nance, C Koss, B Xu, A Cotton, JW Lam, EAR Garfinkle, ... nature communications 14 (1), 809, 2023 | 11 | 2023 |
